AlphAIalphai — Financial news for AI agents
SEC EDGARJUL 12 min read$TEM

LEFKOFSKY ERIC P sold $9.6M of TEM (indirect holdings)

LEFKOFSKY ERIC P (CEO and Chairman) sold 166,250 indirectly-held shares of Tempus AI, Inc. (TEM) at an average of $57.48 ($55.38–$59.23, $9.56M total) across 10 trades on 2026-06-29 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · LEFKOFSKY ERIC P
Published Jul 1, 2026, 8:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 1, 2026, 8:20 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$TEM
Neutral
medium confidence
Mentioned
$TEM
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TEMNeutralLow
01

Why it matters

The newest actionable element is the disclosed sale size (~166,250 shares; ~$9.56M) and the stated 10b5-1 pre-arranged plan, which frames the transaction as planned rather than opportunistic.

02

Market read

Newly filed insider-sale data can influence short-term sentiment, but 10b5-1 labeling typically limits interpretive weight.

03

What to watch

Traders may overreact to insider sales; the key is whether subsequent filings show sales outside the planned schedule or changes in total insider ownership trend.

Relevance 5/10Novelty 6/10Timing: after-hours/next-session read-through from a newly filed Form 4 (filed 2026-07-01)

Background

The article is an SEC Form 4 insider transaction disclosure for Tempus AI, Inc. (TEM) by CEO/Chairman Eric P. Lefkofsky, executed across multiple trades on 2026-06-29.

Company-level read

Ticker impact

$TEMNeutralMedium confidence
Context

Tempus AI CEO/Chairman Eric P. Lefkofsky sold ~$9.56M of TEM shares via a 10b5-1 plan on 2026-06-29 at $55.38–$59.23.

Expected impact

Likely limited, short-lived sentiment impact; watch for follow-through only if selling accelerates beyond planned cadence.

Evidence & confidence

The filing is primary-source and time-stamped, but it explicitly states a pre-arranged 10b5-1 plan, which typically dampens interpretation as new negative information.

Market effects

Sector

Minimal; this is company-specific insider transaction with no sector-wide catalyst.

Regional

Minimal; no broader macro or regional linkage in the filing details.

Global

Minimal; no international deal/regulatory action described.

Counterpoint

What could challenge this read

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may be routine liquidity management rather than a bearish signal.

Key entities

  • issuer
    Tempus AI, Inc.

    Subject of the Form 4 insider sale; CEO/Chairman Eric P. Lefkofsky sold shares under a 10b5-1 plan.

  • insider
    LEFKOFSKY ERIC P

    CEO and Chairman; sold 166,250 shares indirectly on 2026-06-29 at $55.38–$59.23 (weighted avg $57.482).

Read at source← All news

Related articles

AUG 7
$TEMMed

Why Is Tempus AI Stock Surging on Friday? - Tempus AI (NASDAQ:TEM)

Tempus AI Inc. (NASDAQ:TEM) shares rose about 11% on Friday, outperforming the Nasdaq and the Healthcare sector, amid an AI-healthcare sector rally. The move followed strong peer results, including Doximity’s fiscal Q1 revenue of $156.6 million, and a strategic collaboration with CellCarta adding Tempus to its CDx lab network. TEM traded near $50.95.

benzinga.com4 min
AUG 3
$TEMMed

BTIG cuts Tempus AI stock price target to $70 on model update

BTIG cut its Tempus AI (NASDAQ:TEM) price target to $70 from $80 while keeping a Buy rating after the company’s Q2 2026 earnings call. Tempus AI reported 22% YoY revenue growth, raised 2026 revenue guidance to 25% to 26%, and posted $382.5M revenue with an adjusted EPS loss of $0.04. BTIG cited Tempus’s $1.5B Personalis deal with a $46 stock-price termination trigger.

investing.com3 min
JUL 31
$TEMMedAI 8/10

Dear Tempus AI Stock Fans, Mark Your Calendars for July 30

Tempus AI (NASDAQ: TEM) agreed to acquire Personalis (PSNL) for $16.25 per share in stock, valuing the deal at about $1.5 billion enterprise value net of Tempus’ existing stake, with closing expected late 2026 or early 2027. Tempus expects integration to expand MRD capabilities. After the July 20 announcement, TEM fell 7.74% intraday. In Q1, revenue rose 36.1% to $348.12M. Needham reiterated Buy at $75; consensus target is $66.75.

yahoo.com5 min
JUL 31
$TEMMedAI 8/10

Tempus AI Raises FY2026 Sales Guidance to $1.595B-$1.605B

Tempus AI (NASDAQ: TEM) has raised its full-year 2026 sales guidance, signaling robust demand for its artificial intelligence-driven healthcare solutions. The company updated its revenue outlook to a range of $1.595 billion to $1.605 billion, an increase from the previous guidance of $1.590 billion to $1.600 billion.

scanx.trade5 min
JUL 30
$TEMMedAI 8/10

Tempus AI Q2 Results: Revenue rises 22% YoY, stock slides

Tempus AI (NASDAQ: TEM) reported second-quarter revenue of $382.5 million, rising 22% year-over-year and surpassing Street consensus estimates of $379.7 million. Despite the top-line beat and a narrower-than-expected loss per share of four cents versus an estimated 14 cents loss, shares declined 2.4% in after-hours trading to $43.25.

scanx.trade5 min